Anterogen.Co.Ltd Market Cap ($70.45 Million)

$70.45 Million USD · ₩103.95 Billion KRW · Rank #20375

Market Cap & Net Worth: Anterogen.Co.Ltd (065660)

Anterogen.Co.Ltd market cap. Anterogen.Co.Ltd (KQ:065660) has a market capitalization of $70.45 Million (₩103.95 Billion) as of November 4, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #20375 globally and #1108 in its home market, demonstrating a -8.67% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Anterogen.Co.Ltd's stock price ₩13070.00 by its total outstanding shares 7953630 (7.95 Million). Also see cash flow conversion of Anterogen.Co.Ltd for how efficiently the company converts equity into cash flow.

Anterogen.Co.Ltd Market Cap History (2016–2026)

Anterogen.Co.Ltd market cap history from 2016 to 2026. Data shows change from $127.74 Million to $70.45 Million (-9.71% CAGR). Check Anterogen.Co.Ltd share price for real-time trading data and today's change.

Index Memberships

Anterogen.Co.Ltd is a constituent of 2 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
Kosdaq Composite Index KOSDAQ	$203.83 Billion	0.03%	#478 of 1384
Kosdaq Composite Index KQ11	$203.83 Billion	0.03%	#478 of 1384

Weight: Anterogen.Co.Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Anterogen.Co.Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Anterogen.Co.Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Anterogen.Co.Ltd to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

0.01x

Anterogen.Co.Ltd's market cap is 0.01 times its annual revenue

Industry average: 0.00x Higher than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$127.74 Million	$4.90 Billion	$371.66 Million	0.03x	0.34x
2017	$247.94 Million	$5.36 Billion	$446.74 Million	0.05x	0.56x
2018	$381.08 Million	$3.61 Billion	-$961.76 Million	0.11x	N/A
2019	$231.23 Million	$4.15 Billion	-$4.05 Billion	0.06x	N/A
2020	$335.80 Million	$4.15 Billion	-$4.38 Billion	0.08x	N/A
2021	$346.58 Million	$8.12 Billion	-$553.98 Million	0.04x	N/A
2022	$79.23 Million	$6.59 Billion	-$6.84 Billion	0.01x	N/A
2023	$92.12 Million	$6.50 Billion	-$2.84 Billion	0.01x	N/A
2024	$101.82 Million	$6.93 Billion	-$2.29 Billion	0.01x	N/A

Competitor Companies of 065660 by Market Capitalization

Companies near Anterogen.Co.Ltd in the global market cap rankings as of November 4, 2026. Also see Anterogen.Co.Ltd balance sheet assets for a full breakdown of the balance sheet.

Key companies related to Anterogen.Co.Ltd by market ranking:

Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #5272 globally with a market cap of $2.49 Billion USD ( ₩3.67 Trillion KRW).
ST Pharm Co.Ltd (KQ:237690): Ranked #8989 globally with a market cap of $902.70 Million USD ( ₩1.33 Trillion KRW).
NatureCell Co.Ltd (KQ:007390): Ranked #9557 globally with a market cap of $793.12 Million USD ( ₩1.17 Trillion KRW).
Oscotec Inc (KQ:039200): Ranked #10371 globally with a market cap of $674.16 Million USD ( ₩994.80 Billion KRW).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#5272	Sam Chun Dang Pharm. Co. Ltd	KQ:000250	$2.49 Billion	₩171400.00
#8989	ST Pharm Co.Ltd	KQ:237690	$902.70 Million	₩71400.00
#9557	NatureCell Co.Ltd	KQ:007390	$793.12 Million	₩22050.00
#10371	Oscotec Inc	KQ:039200	$674.16 Million	₩35400.00

Market Capitalization of Anterogen.Co.Ltd (2016–2026)

Market capitalization of Anterogen.Co.Ltd from 2016 to today. Between 2016 and today, Anterogen.Co.Ltd's market cap moved from $127.74 Million to $ 70.45 Million, with a yearly change of -9.71%.

Year	Market Cap	Change (%)
2026	₩70.45 Million	-72.10%
2025	₩252.52 Million	+148.01%
2024	₩101.82 Million	+10.53%
2023	₩92.12 Million	+16.26%
2022	₩79.23 Million	-77.14%
2021	₩346.58 Million	+3.21%
2020	₩335.80 Million	+45.22%
2019	₩231.23 Million	-39.32%
2018	₩381.08 Million	+53.70%
2017	₩247.94 Million	+94.09%
2016	₩127.74 Million	--

End of Day Market Cap According to Different Sources

On Nov 4th, 2026 the market cap of Anterogen.Co.Ltd was reported to be:

Source	Market Cap
Yahoo Finance	$70.45 Million USD
MoneyControl	$70.45 Million USD
MarketWatch	$70.45 Million USD
marketcap.company	$70.45 Million USD
Reuters	$70.45 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Anterogen.Co.Ltd

KQ:065660 Korea Pharmaceuticals

Market Cap

$70.45 Million

₩103.95 Billion KRW

Market Cap Rank

#20375 Global

#1108 in Korea

Share Price

₩13070.00

Change (1 day)

-3.61%

52-Week Range

₩13070.00 - ₩58000.00

All Time High

₩197700.00